How Heart Cells Use FGF2 to Talk to Nerves
Beneath every heartbeat lies a secret conversation—a continuous molecular dialogue between your heart muscle cells and the nervous system that controls them.
For decades, scientists have known that the heart communicates with nerves, but the precise language of this exchange remained mysterious. The discovery that cardiomyocytes (heart muscle cells) release sophisticated chemical signals that directly influence sympathetic ganglion neurons has opened new frontiers in cardiovascular science.
Central to this conversation is Fibroblast Growth Factor 2 (FGF2), a protein that heart cells package into conditioned medium—the liquid environment that bathes cells in laboratory experiments.
This molecular messenger represents a fundamental communication channel that helps explain how the heart maintains its intricate neural networks and how this system falters in disease. Recent research reveals that these signaling mechanisms are not just biological curiosities—they hold transformative potential for treating heart attacks, arrhythmias, and heart failure by addressing the crucial neural component of heart health that existing medications largely overlook 1 .
Understanding the fundamental components of cardiac neural communication
In laboratory research, conditioned medium serves as a molecular treasure trove—it's the liquid that has bathed living cells and contains the complete cocktail of proteins, growth factors, and other signaling molecules those cells naturally secrete.
When scientists collect medium conditioned by cardiomyocytes, they're essentially gathering the heart cells' outgoing messages to their environment. This approach has been instrumental in identifying key cardiac signaling molecules 4 .
FGF2 is a protein that heart muscle cells produce and release, particularly when stressed by conditions like hypertension, oxygen deprivation (hypoxia), or ischemia .
In the heart, FGF2 plays a crucial protective role during stress events like heart attacks. Research has demonstrated that mice lacking FGF2 develop significantly less cardiac hypertrophy (40-52% less) in response to pressure overload compared to normal mice 2 .
The sympathetic neurons that control heart function form specialized contact points called neuro-cardiac junctions (NCJs) 1 .
These junctions are the microscopic communication hubs where nerve cells release neurotransmitters that directly influence heart muscle cells. This creates a continuous feedback loop where each cell type supports the other's function and survival.
| Component | Function | Significance |
|---|---|---|
| Conditioned Medium | Contains secreted factors from cardiomyocytes | Allows study of cell communication without preconceived ideas about which molecules matter |
| FGF2 | Protective growth factor released during stress | Helps heart adapt to pressure overload and ischemia |
| Neuro-cardiac Junctions | Specialized contact points between nerves and heart cells | Enable precise, localized communication between different cell types |
| Nerve Growth Factor (NGF) | Sustains sympathetic neuron survival | Provided by cardiomyocytes to maintain their neural connections |
Hypertension, ischemia, or hypoxia
Cardiomyocytes secrete FGF2
Sympathetic neurons receive signal
Heart function adjusts to stress
Cardiac stress such as hypertension, ischemia, or hypoxia triggers the communication process between cardiomyocytes and sympathetic neurons.
How researchers demonstrated FGF2's non-redundant function in cardiac stress response
To truly understand how FGF2 functions in heart-neural communication, scientists designed an elegant experiment using genetically modified mice, providing compelling evidence for FGF2's non-redundant role in cardiac stress response 2 .
The team studied mice with a targeted disruption of the Fgf2 gene (Fgf2-/-), comparing them to normal mice (Fgf2+/+) 2 .
To simulate conditions similar to human hypertension, researchers performed aortic coarctation—a procedure where they placed a constricting band around the aorta, forcing the heart to work against increased resistance 2 .
For ten weeks post-surgery, the team used echocardiography to meticulously track changes in heart wall thickness, chamber size, and function, creating a detailed picture of how the hearts adapted to pressure overload 2 .
Researchers examined heart tissue for changes in gene expression patterns, particularly focusing on the reversion to fetal genetic programs that typically occurs in stressed heart muscle 2 .
The findings were striking in their clarity. Mice lacking FGF2 demonstrated a severely blunted hypertrophic response—their hearts enlarged only 4-24% compared to 41-52% in normal mice 2 . This dramatic difference revealed that FGF2 isn't just one of many factors involved in cardiac adaptation; it plays a central, non-redundant role in how the heart responds to mechanical stress.
Increase in LV Mass
Significant cardiomyocyte enlargement
Blunted β-adrenergic response after overload
Increase in LV Mass
Reduced cardiomyocyte enlargement
Similar to non-stressed β-adrenergic state
| Parameter | Fgf2+/+ Mice (Normal) | Fgf2-/- Mice (FGF2-Deficient) | Significance |
|---|---|---|---|
| Increase in LV Mass | 41-52% | 4-24% | FGF2 essential for normal hypertrophic response |
| Cardiomyocyte Size | Significant increase | Reduced enlargement | Direct effect on heart muscle cells rather than other tissues |
| β-adrenergic Response | Blunted after overload | Similar to non-stressed state | Affects functional adaptation to stress |
| Mitotic Activity | No increase | No increase | Hypertrophic rather than hyperplastic growth |
Further testing showed that the absence of FGF2 affected functional adaptation too. While normal and FGF2-deficient mice had similar responses to β-adrenergic stimulation before surgery, the normal mice developed the expected blunted response to adrenaline-like stimulation after pressure overload—a adaptation that was significantly impaired in FGF2-deficient animals 2 .
Perhaps most importantly, the research demonstrated that FGF2 specifically regulates the structural enlargement of heart muscle cells without triggering cell division (a process called "mitotic growth"), confirming its role in physiological hypertrophy rather than abnormal growth patterns 2 .
Key components for studying neuro-cardiac communication
Studying the complex relationship between cardiomyocytes, FGF2, and sympathetic neurons requires specialized laboratory tools and techniques. Here are key components of the modern cardiovascular researcher's toolkit:
| Research Tool | Function/Application | Experimental Importance |
|---|---|---|
| Cardiomyocyte Conditioned Medium | Contains cardiomyocyte-secreted factors including FGF2 | Allows study of how heart cells influence neurons without direct contact |
| Superior Cervical Ganglion Neurons | Source of sympathetic neurons for co-culture studies | Enable creation of simplified neuro-cardiac systems in laboratory dishes |
| Laminin-Coated Surfaces | Extracellular matrix protein coating culture surfaces | Mimics natural environment, helping maintain cell health and function |
| Low-Glucose, Serum-Free Medium | Defined culture medium with specific composition | Promotes cardiomyocyte maturation and reduces non-myocyte contamination |
| Nerve Growth Factor (NGF) | Neurotrophic factor added to co-cultures | Supports survival and maintenance of sympathetic neurons in laboratory settings |
| Immunofluorescence Staining | Technique using antibodies to visualize specific proteins | Allows researchers to see neuro-cardiac junctions and protein localization |
Microphysiological systems (MPS)—sophisticated laboratory platforms that mimic human organ functions—are increasingly valuable as they "offer an advanced in vitro platform that can be used to study human organ and tissue level functions in health and in diseased states more accurately than traditional single cell cultures or even animal models" 3 .
These systems allow researchers to create more human-relevant models of neuro-cardiac interaction without relying solely on animal studies.
Techniques like immunoisolation have enabled scientists to isolate specific subpopulations of vesicles and exosomes from conditioned medium, allowing them to study precisely how FGF2 and other signals are packaged and delivered 4 .
This level of precision has been crucial for understanding the specific mechanisms of cardiac-neural communication.
The discovery of FGF2's role in cardiomyocyte-sympathetic ganglion communication has opened promising therapeutic avenues. Researchers are exploring how to harness this knowledge to develop novel treatments for cardiovascular diseases that account for the crucial neural component of heart health.
One particularly exciting approach involves creating advanced neuro-cardiac co-culture systems that more accurately replicate human physiology. Recent research has demonstrated that "a defined low-glucose, serum-free (LGSF) culture protocol... drives the structural and functional maturation of neonatal CMs and supports their integration into functional neuro-cardiac co-cultures" 5 .
These improved laboratory models allow scientists to study neuro-cardiac communication with unprecedented precision, potentially accelerating drug discovery.
The therapeutic implications are substantial. Since abnormal sympathetic innervation contributes to conditions like myocardial infarction, hypertrophy, and arrhythmias 5 , understanding how to modulate this neural network through factors like FGF2 could lead to groundbreaking treatments.
Scientists are exploring everything from drug therapies that enhance protective signaling to sophisticated approaches using exosomes as natural delivery vehicles for cardioprotective factors 7 .
As research continues to unravel the complex dialogue between the heart and its nerves, each discovery brings us closer to a future where we can not just treat heart disease but actually restore the heart's natural communication networks—offering hope for millions living with cardiovascular conditions.
References will be added here in the proper citation format.